This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation ResearchLaboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.
Molecules on its surface (yellow) allow researchers to attach the viral spike protein (purple), which SARS-CoV-2 depends on to infect human cells. Because SARS-CoV-2 is so highly infectious, basic researchers without access to specially designed biosafety facilities may be limited in their ability to study the virus. That’s now.
By Makenzie Kohler October 17, 2023 Credit: Allison Colorado, Broad Communications Amy Deik is a research scientist and lab manager in the Metabolomics Platform. She’d always had an interest in genetics research and moved to Boston in 2002 to work for a genetics-focused startup. What do you do as a research scientist at Broad?
Researchers from UCLA and the United States Army ResearchLaboratory have laid out a new approach to enhance artificial intelligence-powered computer vision technologies by adding physics-based awareness to data-driven techniques.
The Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, is equipping AFWERX — a technology directorate of the Air Force ResearchLaboratory (AFRL) and the innovation arm of the Department of the Air Force — with capabilities to quickly and safely test autonomous vehicles in complex, interactive environments.
Army Combat Capabilities Development Command (DEVCOM) Army ResearchLaboratory and executed by the Civil-Military Innovation Institute. The University of Arkansas has become the latest university to join the Army Pathfinder Program, an initiative overseen by the U.S.
They are often the method of choice to detect or measure specific biological molecules (analytes) for diagnostics, drug discovery or fundamental research. Early beginnings ELISAs were first developed in the mid-1970s independently by two research groups. Many proven applications The use of ELISAs has flourished in the life sciences.
In the current study undertaken by an international team of researchers, co-led by Dr William Reay, we used the genetics of retinol itself as a way to proxy its effect in thousands of traits, including brain structure, vision, and the immune system through causal modelling.
Dr Brass has published over 85 peer reviewed articles and more than 200 abstracts, primarily in the field of hepatology, in both the areas of clinical and basic science research. He is named on 15 patents relating to drug development in liver disease.
has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer. “I (NYSE: PFE) today announced that Annaliesa Anderson, Ph.D.,
Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. Acta Cryst. Acta Cryst. 2013) 56, 2059-2073.
Perlmutter, President, Merck ResearchLaboratories. “We We hope that the combined efforts of Merck ResearchLaboratories and A2 Biotherapeutics will enable the application of this ingenious approach to improve the treatment of patients suffering from refractory solid tumors.”.
It’s an investment in the long-term success of rare disease research, even if it doesn’t provide an immediate clinical on-ramp. Rebecca Shi of Stanford University, who worked to create a researchlaboratory course for undergraduates in the Stanford Biology department for the Spring 2023 semester. What Can We Learn From A Worm?
An article in STAT (which Sharon Begley spent more than a year reporting) about an “Alzheimer’s cabal” questioned, and then shifted, the priorities of a research field. Saloni Dattani , researcher on global health at Our World in Data ; founding editor at Works in Progress magazine. We think so.
Researchers randomized patients to either 4,200 mg of IV-administered bamlanivimab or placebo and saw that after eight weeks of participant follow-up, the 965 participants who tested negative for the virus at baseline saw a 57 percent lower frequency of symptomatic COVID-19 in the drug arm compared to the placebo arm.
Xander Balwit offers concrete proposals for raising the welfare of animals used in biomedical research for our final article in Issue 03. Of course, AA and P-line rats are not the only research animals bred for the study of disease. We’ll be on a brief hiatus for the next few weeks as we prepare for the next Issue!
What is the difference between a Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory vs a researchlaboratory? The Centers for Medicare & Medicaid Services (CMS) regulates all clinical laboratory testing performed on human samples in the US through CLIA.
Merck and Eisai are committed to working together to continue to explore the potential of the KEYTRUDA plus LENVIMA combination, particularly in areas of great unmet need such as renal cell carcinoma.”. “We It is very clear that in this study, the addition of ipilimumab did not add clinical benefit but did add toxicity.
“These new data from our LEAP clinical program show encouraging activity across several aggressive cancer types and expand our knowledge about the potential of KEYTRUDA plus LENVIMA to help a range of patients with these cancers,” said Scot Ebbinghaus, vice president, Clinical Research, Merck ResearchLaboratories.
In a quiet New York town, an amateur scientist has constructed a fully equipped researchlaboratory in which to advance plant biology research. ” Earlier this year, we sent a photographer to Sebastian’s home laboratory. We need more people focusing on the intersection between participatory and actual research.
Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck ResearchLaboratories (MRL), will be retiring from Merck in July. Li, president, Merck ResearchLaboratories, until his retirement. He also led the expansion of Merck’s research and development in China and Japan. “It
The condition “is difficult to treat and the underlying drivers and natural history of the disease are not fully established,” noted Professor Claus Bachert, head of the Department of Oto-Rhino-Laryngology and chair of the Upper Airway ResearchLaboratory, University Hospital Ghent, Belgium, the principal investigator of the trial.
As money poured into wartime research programs, physics shifted from a field of brilliant individuals to one of well-managed teams. Biology has had a few large-scale research programs, such as the Human Genome Project , but nowhere near the same number as physics. For one, biology research is inherently broad.
As viruses evolve over time, new, agile research applications need to be created to combat these evasive intruders from exploiting host cells. The handling of these pathogens needs to take place in researchlaboratories that are designated as biosafety level 3 or higher due to its dangerous infectious nature.
Hyman currently serves as director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard and is the Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Evenstad served as chief executive officer of Upsher-Smith Laboratories.
“Triple-negative carcinoma grows and spreads faster than other sorts of carcinoma and consequently features a worse prognosis,” said Dr. Vicki Goodman, vice chairman , clinical research, Merck ResearchLaboratories. Merck has the industry’s largest immuno-oncology clinical research program. Source link: [link].
AUTOMATION CAN OVERCOME BOTTLENECKS IN SYNTHETIC BIOLOGY PIPELINES Daniels’ talk entitled Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors outlines a recent client collaboration with the Air Force ResearchLaboratory (AFRL) where Strateos’ automated cloud lab was leveraged to accelerate rational (..)
Improper disposal of antibiotics also releases these drugs into the environment, and researchers working with these drugs in the lab also have concern over their ultimate effects on study results. The process described in the research was previously developed by a former graduate student research in O’Malley’s lab, Justin Yoo.
The Award recognizes the research that has the highest translational potential Translational medicine is an interdisciplinary branch in the biomedical field that aims to combine benchside, bedside and community to promote enhancement in prevention, diagnosis, and treatment. This year, Prof. Boehringer Ingelheim.
Researchers found that the cocktail prevented symptomatic infection in all 186 participants who were given a 1,200-mg injected dose, compared to eight of 223 placebo patients who developed symptoms. The early analysis is from a National Institutes of Health- (NIH) supported trial in 409 participants.
The data were presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, held virtually April 10-15, 2021. Loxo Oncology at Lilly was created in December 2019, combining the Lilly ResearchLaboratories oncology organization and Loxo Oncology, which was acquired by Lilly in early 2019.
“While the treatment landscape has evolved, an unmet need remains for appropriate patients newly diagnosed with certain types of advanced urothelial carcinoma who are not eligible for platinum-containing chemotherapy,” said Dr. Scot Ebbinghaus, vice president, clinical research, Merck ResearchLaboratories. “We
Roy Baynes, Senior Vice President and Head of Global Clinical Development, Chief Medical Officer at MSD ResearchLaboratories, said: “HRD is an important biomarker of advanced ovarian cancer that can inform how physicians in the EU treat this aggressive type of cancer. months versus 35.3 months with bevacizumab.
When time is critical to the success of your laboratory’s mission, you need proven solutions that connect seamlessly and support your end-to-end workflow.
Davis, current executive vice president, global services and chief financial officer; as previously announced ( link ), Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions – Human Health, Animal Health, Manufacturing, and Merck ResearchLaboratories – will begin reporting to him.
This collaboration with the Lieber Institute further expands our innovative neuropsychiatric research program, a key focus area at Boehringer Ingelheim, with a first-in-class mechanism that may have the potential to address these symptoms,” said Dr. Hugh Marston, Ph.D., Head of Department CNS Diseases Research at Boehringer Ingelheim. “By
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Kumquat Biosciences today announced an exclusive collaboration focused on the discovery, development and commercialization of potential novel small molecules that stimulate tumor-specific immune responses.
As money poured into wartime research programs, physics shifted from a field of brilliant individuals to one of well-managed teams. Biology has had a few large-scale research programs, such as the Human Genome Project , but nowhere near the same number as physics. For one, biology research is inherently broad.
“Since its first approval in renal cell carcinoma nearly two years ago, KEYTRUDA has become an important first-line treatment option in combination with axitinib for patients with advanced renal cell carcinoma,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck ResearchLaboratories.
“It continues to be critically important to advance potential antiviral treatments to address the devastating impact of COVID-19 globally,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck ResearchLaboratories. “If
“We continue to make progress in our Phase 2/3 clinical programs evaluating molnupiravir in both outpatient and hospital settings and plan to provide updates when appropriate,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck ResearchLaboratories. About Molnupiravir.
An article in STAT (which Sharon Begley spent more than a year reporting) about an “Alzheimer’s cabal” questioned, and then shifted, the priorities of a research field. Saloni Dattani , researcher on global health at Our World in Data ; founding editor at Works in Progress magazine. We think so.
I think we have to be aware about that,” said study author Jude Mary Cenat, director of the Vulnerability, Trauma, Resilience and Culture ResearchLaboratory at the University of Ottawa in Canada.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content